Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Ketamine tablet prescription laws rest on three layers: federal drug scheduling, FDA rules on off-label prescribing and pharmacy compounding, and state-level telehealth and medical-practice statutes. No layer bans oral ketamine tablets outright, but each one sets conditions a prescriber and pharmacy must meet before a prescription is legal to write and fill.
This is educational information, not legal or medical advice. Rules around telehealth and controlled-substance prescribing have shifted more than once since 2020, so confirm the current requirements with a licensed prescriber before making a decision based on this article.
Quick Answer
Ketamine is a Schedule III controlled substance under the federal Controlled Substances Act, so any prescriber must hold an active DEA registration and any dispensing pharmacy must be licensed to handle Schedule III drugs. Oral ketamine tablets for depression, anxiety, or pain are prescribed off-label, since only esketamine nasal spray (Spravato) has FDA approval for a psychiatric use. Compounded tablets are made under FDA Section 503A and state pharmacy board oversight rather than standard FDA drug approval, and telehealth prescribing must follow the Ryan Haight Act's in-person evaluation rule and any current DEA extensions.
Federal Law: Ketamine's Schedule III Status
Ketamine is classified as a Schedule III controlled substance under the federal Controlled Substances Act, the law the U.S. Drug Enforcement Administration (DEA) uses to regulate drugs with an accepted medical use and a moderate potential for abuse or dependence. That classification means any clinician who prescribes ketamine tablets, including compounded oral or sublingual formulations, must hold an active DEA registration number, and pharmacies that dispense them must be licensed to handle Schedule III substances. Scheduling doesn't dictate which condition a prescriber can treat; it governs who may legally prescribe and dispense the drug and how records must be kept.
Key Facts on Ketamine's Legal Status
Why Oral Ketamine for Depression Is an Off-Label Prescription
The FDA approved ketamine as an anesthetic in 1970, not as a treatment for depression or other mental health conditions. The only ketamine-derived medication with FDA approval for a psychiatric indication is esketamine nasal spray (Spravato), which the agency approved in March 2019 for treatment-resistant depression when used with an oral antidepressant. Oral ketamine tablets prescribed for depression, anxiety, or chronic pain are therefore off-label, a legal and common practice in U.S. medicine in which a licensed physician prescribes an FDA-approved drug for a use, dose, or route the FDA hasn't specifically evaluated. Off-label prescribing is legal as long as the prescriber has a legitimate medical purpose and documents the clinical reasoning, but it also means the tablet formulation, dose, and depression indication haven't gone through the FDA's standard efficacy review the way Spravato has.
Compare tablet options
Review tablets versus troches, IV infusion, and other routes before deciding what to ask.
Compare optionsCompounded Tablets and Pharmacy Regulation
No pharmaceutical company sells an FDA-approved oral ketamine tablet, so prescriptions are filled by compounding pharmacies that prepare the medication from bulk ketamine to a prescriber's specific dose and formulation. Compounding pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act, which the FDA oversees alongside state boards of pharmacy that license and inspect the facilities. Compounded drugs are not FDA-approved products, the agency doesn't independently verify the safety, effectiveness, or manufacturing consistency of a compounded formulation the way it does for approved medications, so the compliance burden shifts to the pharmacy's state licensing and the prescriber's oversight. Before filling a prescription, it's reasonable to ask a pharmacy about its accreditation; see our guide to compounded ketamine tablets pharmacy questions for what to ask.
Telehealth Prescribing Rules
Federal telehealth law adds a layer specific to controlled substances. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 generally requires a prescriber to complete at least one in-person medical evaluation before prescribing a Schedule III drug like ketamine through telemedicine. The DEA suspended that in-person requirement during the COVID-19 public health emergency and has extended the flexibility for telehealth prescribing of controlled substances several times since. The exact expiration date and any permanent telemedicine rule have changed more than once, so confirm the current status directly with the DEA's telemedicine guidance or your prescriber before assuming a video-only evaluation is sufficient.
Telehealth Rules Keep Changing
DEA flexibilities that let prescribers evaluate patients by video alone for controlled substances like ketamine have been extended multiple times since 2020, and requirements can change with little notice. Confirm the current in-person evaluation rule with your prescriber and check the DEA's telemedicine page before relying on a telehealth-only intake.
State Laws Add Another Layer
States regulate the practice of medicine and pharmacy independently of federal scheduling, so requirements for a ketamine tablet prescription vary by where you live and where your prescriber is licensed. Common state-level variables include whether a prescriber needs a separate telehealth registration to treat patients across state lines, how many days' supply a pharmacy can dispense at once, and whether a state medical board has issued specific guidance on off-label ketamine prescribing for psychiatric use. Federal policy shifts can also filter down to state programs, see our coverage of the 2026 executive order on psychedelics and ketamine access for how that plays out. A prescriber licensed in your state, working with a pharmacy licensed in your state, is the baseline legal setup for a ketamine tablet prescription.
What a Legally Compliant Prescription Looks Like
A legitimate ketamine tablet prescription starts with a documented clinical evaluation, typically a psychiatric intake, a review of your medical history, and a discussion of why oral ketamine fits compared with ketamine troches, intranasal ketamine, or IV infusion. From there, the prescriber issues a controlled-substance prescription to a licensed compounding pharmacy, and you're typically expected to follow a monitoring schedule that includes blood pressure checks and periodic check-ins, since Schedule III status and off-label use both call for closer follow-up than a routine prescription. Cost and insurance coverage are separate questions from legality. See oral ketamine tablets cost without insurancedoes Medicare cover ketamine tabletsdoes Medicaid cover oral ketamine tablets, and can you use FSA or HSA funds for ketamine tablets for the financial side of access.
Key Takeaway
Ketamine tablets are legal to prescribe off-label in the U.S. when a DEA-registered prescriber issues the prescription and a licensed compounding pharmacy fills it, but no oral ketamine tablet is FDA-approved for depression, so the legal footing rests on off-label prescribing and compounding rules rather than a standard drug approval.
What to Verify Before You Start
- Confirm your prescriber holds an active DEA registration for controlled substances
- Ask whether your evaluation meets in-person or telehealth requirements under current DEA rules
- Verify the dispensing pharmacy is a licensed compounding pharmacy registered with your state board of pharmacy
- Request written documentation of the off-label rationale and monitoring plan
- Check your state's specific telehealth and controlled-substance prescribing statutes
Continue Your Access Research
Ready to Explore a Legitimate Prescription Pathway?
Learn what a compliant evaluation, DEA-registered prescriber, and licensed compounding pharmacy actually look like before you start.
Frequently Asked Questions
Yes. Physicians can legally prescribe FDA-approved drugs off-label, including ketamine, as long as they have a legitimate medical purpose, document their reasoning, and hold an active DEA registration for the Schedule III substance. Depression itself isn't an FDA-approved indication for oral ketamine tablets.
It depends on current DEA telehealth rules, which have changed several times since 2020. The Ryan Haight Act generally requires an in-person evaluation before a controlled substance can be prescribed through telemedicine, though the DEA has extended exceptions; ask your prescriber which rule applies to your state right now.
No. Compounded ketamine tablets are prepared by a licensed compounding pharmacy under FDA Section 503A rules and state pharmacy board oversight, but the FDA doesn't review or approve the safety and effectiveness of individual compounded formulations the way it does for manufactured drugs.
Any licensed physician with an active DEA registration for Schedule III substances can legally write the prescription, but most reputable practices involve a psychiatrist, psychiatric nurse practitioner, or physician experienced in ketamine protocols, given the off-label use and monitoring involved.
A prescription filled by an unlicensed compounding pharmacy or written by a prescriber without a valid DEA registration can create documentation gaps that complicate insurance reimbursement, pharmacy transfers, and continuity of care. Verifying licensing status upfront is one of the simplest ways to avoid that.
Share
Related Reading
Contact Ketamine Tablet
Send corrections, provider questions, or advertising inquiries.